Bristol-Myers Squibb acquires Celgene, marrying Opdivo maker with Revlimid maker

Biopharmaceutical giant Bristol-Myers Squibb reached a deal to acquire Celgene, a maker of treatments for cancer and inflammatory diseases.

     

 

 

Read More